The all-stock deal creates one of the nation's largest independent oil and gas producers, headquartered in Houston, with combined assets poised to reshape the competitive landscape of the shale sector.
Ardelyx, Inc. (NASDAQ: ARDX) has received significant analyst upgrades, with TD Cowen and Jefferies raising price targets ahead of the company's fourth-quarter results. The optimism centers on the commercial trajectory of its flagship drug, tenapanor, for gastrointestinal and kidney conditions.
A truck driver made a miraculous escape moments before a Norfolk Southern train struck his stranded semi during a historic winter storm in Gastonia, N.C. The incident highlights the severe weather's impact on road safety across the state.
Polish online marketplace Erli has filed a lawsuit against dominant rival Allegro, alleging the platform abuses its market power to pressure sellers into maintaining higher prices on competing sites. Allegro denies the accusations, stating its seller benefit programs are voluntary.
Tron founder Justin Sun announces plans to acquire up to $100 million in Bitcoin as prices dip below $77,000, contrasting with corporate treasury losses and broader market caution.
Insiders at Canadian forestry giant Canfor Corporation have been net buyers of the company's shares over the last twelve months, with President Susan Yurkovich leading the activity. The trend signals internal optimism as key executives invest personal capital even above current trading prices.
While low share prices often signal volatility, they can also hide significant upside. We analyze three companies trading under $10—Archer Aviation, Snap, and Opendoor Technologies—that are positioned to defy market expectations in the coming year, driven by sector tailwinds and strategic pivots.
A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
After a historic surge, gold prices have experienced their steepest drop in decades. Yet, analysts point to enduring geopolitical tensions and monetary policy shifts as reasons why the metal's long-term appeal remains intact.
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
Ripple's Chief Technology Officer, David Schwartz, has expressed skepticism about XRP reaching prices of $50 or $100, triggering a debate within the community as the cryptocurrency's value drops significantly this week.
Amid a market environment of stable rates and mixed sentiment, we highlight three companies—spanning biotech, gaming, and tech hardware—whose current share prices appear significantly below their estimated intrinsic value based on cash flow projections.
The Austrian government has granted a two-year renewal for the Wolfsberg lithium mining license, with a final decision on production expected by end-2026 as lithium prices rebound strongly.
Gold prices tumbled from a record $5,600 to $4,770 per ounce, while silver plummeted 31% in a single day—the steepest decline since 1980. Analysts point to shifting U.S. monetary policy expectations and eased geopolitical anxieties as key drivers behind the sudden sell-off.
In a landmark deal reshaping the U.S. energy landscape, NRG Energy has completed its acquisition of LS Power's 13GW natural gas fleet and virtual power plant platform, significantly boosting its capacity and demand-response capabilities in key markets.
Silver prices have erased most of their historic 2025-2026 gains in a dramatic reversal, highlighting the profound and volatile impact of Chinese retail speculation on global commodity markets.
Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.
CONMED's latest earnings reveal a strategic pivot towards higher-growth surgical platforms, moving away from slower gastroenterology lines. While sales climbed, profitability softened, setting the stage for a crucial transition year as the market weighs the company's reset valuation against its ambitious 2026 roadmap.
Global markets opened the week under pressure, with Asian shares and U.S. futures declining amid renewed concerns over an AI sector bubble and falling commodity prices. South Korea's Kospi led losses with a sharp 4.6% drop.
As regional stock markets face headwinds from easing oil prices and shifting geopolitics, income-focused investors are turning to dividend-paying companies for stability and yield. We examine three high-yield opportunities across the textile, banking, and financial sectors.
